April 7 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - AUROBINDO PHARMA RECEIVES USFDA APPROVAL FOR DAPAGLIFLOZIN TABLETS, 5 MG AND 10 MG
AUROBINDO PHARMA - ELIGIBLE FOR 180 DAYS SHARED GENERIC DRUG EXCLUSIVITY FOR DAPAGLIFLOZIN TABLETS
Source text: https://tinyurl.com/rdf89uy8